Litigation finance – the practice of third-party investors funding lawsuits in exchange for a share of any settlement or judgment – has spent years operating at the margins of institutional portfolios. Now it is moving steadily toward the center, as allocators hunting for returns that don’t track equity or bond markets take a harder look at a strategy whose outcomes are determined largely by courtrooms, not central banks.
Why Uncorrelated Returns Are Worth the Complexity
The appeal is structural. Litigation outcomes depend on evidence, legal precedent, and judicial interpretation – none of which have any meaningful relationship to Federal Reserve policy, corporate earnings cycles, or geopolitical risk premiums. When equity markets sold off sharply in recent years, the value of a funded commercial dispute didn’t move with them. That kind of insulation is genuinely rare in a world where nearly every asset class has grown more correlated as institutional capital flows have homogenized global markets.
Pension funds and endowments have been quietly expanding allocations to alternative strategies for this exact reason. Within that broader search, litigation finance occupies a specific niche: it offers defined duration (most cases resolve within two to five years), binary-style payoffs (the funder either recovers principal plus a return multiple or loses the invested capital), and a return profile that doesn’t require a macroeconomic view to underwrite. For an investment committee exhausted by the need to have an opinion on interest rate trajectories, that simplicity is genuinely attractive.
The asset class has also matured considerably. Funds that once focused almost exclusively on plaintiff-side personal injury claims have broadened into commercial arbitration, patent litigation, antitrust cases, and international treaty disputes. Larger funds now run diversified portfolios of dozens of cases across jurisdictions, which softens the blow of any single adverse outcome. That portfolio construction logic – spreading exposure across legally distinct, outcome-independent cases – is something institutional allocators recognize from other alternative credit strategies.
The minimum check sizes required to access top-tier litigation finance managers have historically kept smaller institutions on the sideline. That is changing. A growing number of funds have structured vehicles with lower entry thresholds specifically to capture family office and mid-size endowment capital. Co-investment opportunities alongside larger anchor commitments have also become more common, giving institutions a way to build familiarity with specific case types before committing to a blind-pool fund structure.
How the Underwriting Actually Works
Understanding what makes litigation finance tick requires spending some time with the underwriting process, because that is where the strategy either earns its returns or destroys capital. Funders conduct detailed legal due diligence before committing capital to any case – reviewing the merits of the claim, the creditworthiness or asset base of the defendant (since a winning judgment against an insolvent party is worthless), the likely duration and cost of litigation, and the enforceability of any eventual award. The quality of that legal analysis is what separates disciplined managers from opportunistic ones.
Commercial cases – typically disputes between sophisticated businesses over contracts, intellectual property, or securities – tend to attract the most institutional interest because they come with cleaner documentation and defendants who have identifiable assets. International arbitration cases under investment treaty frameworks are particularly appealing: awards from bodies like the International Centre for Settlement of Investment Disputes carry enforcement mechanisms across more than 150 countries, which gives funders a degree of recovery confidence that domestic litigation often can’t match.
Return multiples vary widely. Single-case investments in high-risk patent disputes might target three to four times invested capital, while portfolio facilities extended to law firms – where the funder provides a credit line against a bundle of ongoing cases – might target more modest but more predictable returns in the range of 20 to 25 percent annually. The diversity of structures within the asset class means that institutional allocators can dial their risk-return expectations depending on which segment they access. It is not a monolithic strategy, and treating it as one is a common mistake among allocators approaching the space for the first time.
Ethical and regulatory considerations sit at the edge of every due diligence conversation. Some jurisdictions restrict or prohibit third-party litigation funding outright, and the regulatory environment continues to evolve – particularly in the United States, where Congress has periodically debated disclosure requirements that would require litigants to reveal the presence of outside funders. Any such disclosure mandate would affect case strategy and settlement dynamics, which is a real but underappreciated risk factor for fund investors to price.
Duration risk is also less predictable than the two-to-five-year median suggests. Appeals can extend timelines significantly, and some international arbitration cases have dragged on for a decade or more. Funds that lack sufficient liquidity buffers or that have structured investor redemptions on fixed schedules can find themselves under pressure when case resolution slips. Institutional allocators with experience in reinsurance sidecars or other event-driven alternatives tend to be better equipped to absorb that kind of timing uncertainty than those coming from more liquid strategies.
The Risks That Don’t Get Enough Airtime
The binary nature of litigation outcomes is the risk that gets the most attention, and rightly so – a funded case that loses at trial returns nothing. But the subtler risk is adverse selection. Because plaintiffs with genuinely strong cases often have access to contingency-fee attorneys and don’t need outside capital, funders sometimes see a disproportionate share of cases that traditional legal funding channels have already passed on. Top managers argue that their proprietary legal underwriting overcomes this dynamic, and in many cases it does. But it is a structural tension worth examining before committing capital to any fund that hasn’t yet demonstrated a multi-cycle track record.
Manager selection, ultimately, is the defining variable in this asset class. Unlike public equities, where index exposure provides a reasonable default, litigation finance has no passive option. Every dollar committed reflects a bet on a specific team’s legal judgment, case sourcing network, and portfolio construction discipline. That concentration of execution risk on the manager is something institutional allocators accustomed to more systematic strategies will need to get comfortable with – and it’s a harder sell to investment committees than the uncorrelated return story alone.
